Biofrontera AG (BFAGY) Financial Statements

Biofrontera AG (BFAGY) files with the U.S. Securities and Exchange Commission under CIK 0001712641. 10KGenie shows its annual statements from SEC filings.

Key Figures, Fiscal Year 2020

Revenue
30.35 million EUR
Net Income
-13.02 million EUR
Total Assets
56.39 million EUR
Net Cash from Operations
-2.85 million EUR

Fiscal year ended Dec 31, 2020. Latest periodic SEC filing: Apr 12, 2021. Source: SEC filings (EDGAR XBRL). Amounts in EUR.

Open the full financial statements for BFAGY in 10KGenie

Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History